The AESKULISA Parvovirus B19 IgG is a qualitative and quantitative immunoassay for the demonstration of human IgG antibodies in serum or plasma directed against Parvovirus B19. The AESKULISA Parvovirus B19 IgG serves for confirmation of a contact with the pathogen and supports in immune status determination.
Virus-like Particels (VLPs) composed of recombinant VP2 produced in baculovirus-infected insect cells
n.a.
AESKU.GROUP位于德国温德尔斯海姆,是一家致力于研究,提供创新和高效产品和服务的研究型供应商,用于早期发现,诊断和预后自身免疫性疾病。
自AESKU.DIAGNOSTICS于2000年成立以来仅十年,就在自身免疫领域广受认可,在全球90多个国家/地区推出了150多种产品以及不间断的服务。